Maplight Therapeutics insider sells 3,213 shares

Maplight Therapeutics reported insider sales by Erin Pennock Foff.

Rhea-AI Filing Summary

Maplight Therapeutics reported insider sales by Erin Pennock Foff. The filing discloses a sale of 2,044 shares for $54,869.99 on 04/15/2026 and a sale of 1,169 shares for $31,997.52 on 04/16/2026. The record shows the securities originated from a vested RSU dated 07/05/2024 and lists Jefferies LLC as the broker-dealer.

Key Figures

Sale on 04/15/2026: 2,044 shares Sale on 04/16/2026: 1,169 shares Form record date: 05/04/2026

3 metrics

Sale on 04/15/2026 2,044 shares sold for $54,869.99 on 04/15/2026

Sale on 04/16/2026 1,169 shares sold for $31,997.52 on 04/16/2026

Form record date 05/04/2026 Form 144 record date shown on the filing

Key Terms

Form 144, vested RSU, broker-dealer

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

vested RSU financial

"Common | 07/05/2024 | Vested RSU"

broker-dealer financial

"Jefferies LLC 520 Madison Avenue, 4th Floor New York NY"

A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for MPLT disclose?

The Form 144 shows insider Erin Pennock Foff sold 2,044 shares ($54,869.99) on 04/15/2026 and 1,169 shares ($31,997.52) on 04/16/2026. It lists a vested RSU dated 07/05/2024.

Who acted as broker for the reported MPLT sales?

The filing lists Jefferies LLC as the broker-dealer handling the transactions. The entry shows the broker address as 520 Madison Avenue, New York, NY with NASDAQ routing noted.

Are the sold shares from compensation or open‑market holdings for MPLT?

The filing identifies the source as a vested RSU dated 07/05/2024, indicating the reported shares originated from equity compensation rather than newly issued shares.

When was the Form 144 record dated for MPLT?

The filing lists a record date of 05/04/2026. The two reported sale dates are 04/15/2026 and 04/16/2026, as shown in the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 05:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002021233
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Foff Erin Pennock
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Avenue, 4th Floor New York NY 10022	54718	1679842.60	42000000	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/05/2024	Vested RSU	Maplight Therapeutics, Inc.			54718	07/05/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Erin Pennock Foff 800 Chesapeake Drive Redwood City CA 94063	Maplight Therapeutics, Inc.	04/15/2026	2044	54869.99
Erin Pennock Foff 800 Chesapeake Drive Redwood City CA 94063	Maplight Therapeutics, Inc.	04/16/2026	1169	31997.52

144: Remarks and Signature

Remarks	All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 12/29/2025, and all representations regarding material non-public information were made as of the adoption of the plan. The securities to be sold were acquired upon the vesting of restricted stock units during the period of 07/05/2024 through 04/01/2026.
Date of Notice	05/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Erin Foff
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)